Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.

ABSTRACT:

Clinical trial registration

www.ClinicalTrials.gov, identifier: NCT04365634.

Context

Diabetes mellitus was associated with increased severity and mortality of disease in COVID-19 pneumonia. So far the effect of type 2 diabetes (T2DM) or hyperglycemia on the immune system among COVID-19 disease has remained unclear.

Objective

We aim to explore the clinical and immunological features of type 2 diabetes mellitus (T2DM) among COVID-19 patients.

Design and methods

In this retrospective study, the clinical and immunological characteristics of 306 hospitalized confirmed COVID-19 patients (including 129 diabetic and 177 non-diabetic patients) were analyzed. The serum concentrations of laboratory parameters including cytokines and numbers of immune cells were measured a

SUBMITTER: Han M 

PROVIDER: S-EPMC7992040 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature